Imatinib Mesylate 42292-0043-03
Generic: Imatinib
- Manufacturer
- Mylan Institutional Inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 7, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA204644
Need to source Imatinib Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 100 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Selected Package
42292-0043-03Selected30 BLISTER PACK in 1 CARTON (42292-043-03) / 1 TABLET, FILM COATED in 1 BLISTER PACK (42292-043-01)